Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07447973

Multimodal Deep Learning Model for Multi-task Diagnosis and Triage Suggestions of Ophthalmic Diseases

Accurate and comprehensive interpretation of anterior segment diseases from slit-lamp and smartphone photographs remains a clinical challenge due to the limited specificity and structure of existing Artificial Intelligence tools. The purpose of this international, multicenter clinical trial is to developed and validated an agent-based framework that integrates vision-language models and large language models to enhance the diagnostic workflow of anterior segment diseases.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University

Guangzhou, Guangdong, 510280, China

Location status: Recruiting

Location contact

Honghua Yu

CONTACT

[email protected]

+8618688888422

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Informed consent obtained;
  • Participants should be sufficiently able to read, write, and understand Chinese or English;
  • For normal participants: individuals should have no concerns related to their eyes.
  • For participants with eye-related chief complaints: individuals should have specific concerns or issues related to their eyes.

Exclusion criteria

  • Incomplete clinical data to support final diagnosis;
  • Patients who, in the opinion of the attending physician or clinical study staff, are too medically unstable to participate in the study safely.

Treatment and study plan

Multimodal Vision-language Model Diagnosis

Diagnostic Test

Multimodal Vision-language Model for Multi-task Diagnosis and Triage Suggestions of Ophthalmic Diseases Patients presenting with complaints of anterior segment diseases first complete a slit-lamp examination or take a mobile phone eye photograph. A multimodal vision-language model uses patient-related images (such as selfies and eye exam photos) to make an intelligent diagnosis. The diagnosis is kept private. The patient then seeks medical attention and undergoes a clinical examination by an experienced clinician. A second experienced clinician then reviews the clinical diagnosis. If the diagnosis agrees, it is considered the gold standard. If there is a discrepancy in the diagnosis, the consensus between the two clinicians is used as the gold standard.

Primary outcomes

  1. Diagnostic accuracy of multimodal vision-language model.

    Time frame: from July 2025 to September 2025

    For each patient, the diagnoses generated by the multimodal vision-language model and the clinical diagnosis provided by skilled clinicians were documented and compared. Consistency between the two diagnoses indicates the program's precision in clinical practice.

Study contacts

Contact information is provided by the study sponsor or research team.

Honghua Yu

CONTACT

[email protected]

+8618688888422

Sponsors and collaborators

Lead sponsor

Guangdong Provincial People's Hospital

Other

Registry information

Official study title

Development and Validation of Multimodal Deep Learning Model for Autonomous Diagnosis, Generative Reporting, and Specialist Referral in Ophthalmic Diseases: An International Multicenter Cohort Study

Important dates

Study start
2026
Primary completion
2027
Study completion
2027
First posted
Mar 4, 2026
Registry last updated
Jul 7, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.